Proteomic signatures in antibiotic research (Q37897212)

25 August 2017

1 reference

title

Proteomic signatures in antibiotic research (English)

1 reference

25 August 2017

author

Julia Elisabeth Bandow

series ordinal

2

1 reference

25 August 2017

Michaela Wenzel

1

0 references

publication date

4 July 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

11

1 reference

25 August 2017

issue

15

1 reference

25 August 2017

page(s)

3256-3268

1 reference

What Is an Antibiotic or an Antibiotic Substance?

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

The role of antibiotics and antibiotic resistance in nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Defensins in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

The health revolution: Medical and socioeconomic advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Über das salzsaure 3.3′-Diamino-4.4′-dioxy-arsenobenzol und seine nächsten Verwandten

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Evolution and ecology of antibiotic resistance genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

What antimicrobial resistance has taught us about horizontal gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

An Enzyme from Bacteria able to Destroy Penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Antibacterial drug discovery in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Forty years of beta-lactam research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

The clinical development and launch of amoxicillin/clavulanate for the treatment of a range of community-acquired infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Chapter 5: Zones of inhibition? The transfer of information relating to penicillin in Europe during World War II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

New antibiotics for antibiotic-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Postgenomic strategies in antibacterial drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

An update on the role of nitrofurans in the management of urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Proteomic approach to understanding antibiotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Dysregulation of bacterial proteolytic machinery by a new class of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

How many modes of action should an antibiotic have?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Harnessing the power of the genome in the search for new antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

The role of genomics in antimicrobial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Functional genomics in antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Structure-based approaches to antibiotic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Gel-based proteomics of Gram-positive bacteria: a powerful tool to address physiological questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Movement of the 3'-end of tRNA through the peptidyl transferase centre and its inhibition by antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Antibacterial targets in fatty acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Synthesis and antibacterial properties of (-)-nor-platencin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

7-Phenylplatensimycin and 11-methyl-7-phenylplatensimycin: more potent analogs of platensimycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Total syntheses of (+/-)-platencin and (-)-platencin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Synthesis and biological evaluation of platensimycin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Isolation, structure and biological activities of platencin A(2)-A(4) from Streptomyces platensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Proteomic signature of fatty acid biosynthesis inhibition available for in vivo mechanism-of-action studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Synthesis and biological evaluation of chromium bioorganometallics based on the antibiotic platensimycin lead structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Beta-lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Fluoroquinolones: structure and target sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Peptide deformylase as an antibacterial drug target: target validation and resistance development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

YkrB is the main peptide deformylase in Bacillus subtilis, a eubacterium containing two functional peptide deformylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

The role of peptide deformylase in protein biosynthesis: a proteomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Daptomycin versus Friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Daptomycin - a novel antibiotic against Gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

A comprehensive proteomics and transcriptomics analysis of Bacillus subtilis salt stress adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

The proteomic response of Mycobacterium smegmatis to anti-tuberculosis drugs suggests targeted pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Quantitative proteomic analysis of drug-induced changes in mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Bacterial proteomics and its role in antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

The impact of transcriptome and proteome analyses on antibiotic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Ribosomes as sensors of heat and cold shock in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Proteome-wide profiling of isoniazid targets in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Essentiality of FASII pathway for Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Antivirulence as a new antibacterial approach for chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

21 January 2018

Brinster et al. reply

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Proteomic Approaches to Antibiotic Drug Discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Synthesis and Biological Evaluation of Ferrocene-Containing Bioorganometallics Inspired by the Antibiotic Platensimycin Lead Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

Corynebacterium glutamicum exhibits a membrane-related response to a small ferrocene-conjugated antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100046

21 January 2018

Identifiers

DOI

10.1002/PMIC.201100046

1 reference

25 August 2017

1 reference